The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef

Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20050994
Smyth et al.

• Figure S1 Anti-NKG2D mAb is without effect in NK cell- or T cell-deficient mice.

• Figure S2 Anti-NKG2D mAb effectively neutralizes NKG2D.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef

  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS